Jefferies Group LLC Exelixis, Inc. Put Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $1.82 Million - $2.38 Million	96,100 Added 240.85%	136,000 $2.91 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $1.13 Million - $1.43 Million	-57,600 Reduced 59.08%	39,900 $950,000
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $1.06 Million - $1.69 Million	77,500 Added 387.5%	97,500 $1.92 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $317,400 - $448,000	20,000 New	20,000 $354,000

500

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.1B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.